Unity™ VCS in Japan: Why “Performance” Alone Doesn’t Decide Adoption

Alcon introduced its next-generation surgical platform, Unity™ VCS, at the 2025 Japanese Society of Ophthalmology.

While the device is often discussed in terms of performance upgrades,
in Japan, the conversation quickly shifts to a different question:

“Will this actually work in our system?”

In Japan, adoption is not about features — it’s about sustainability

Unity VCS delivers clear technical improvements:

• 4D Phaco for efficient lens removal
• Up to 30,000 cpm cutter speed
• Active Sentry + temperature sensor
• Multi-pump fluidics system

However, in Japanese clinical settings,
these features are only the starting point.

👉 What truly matters is:

• Case volume
• Procedure mix (cataract vs vitrectomy)
• Operational efficiency
• Cost structure (including consumables)

The structural difference: cataract vs vitrectomy

One key context in Japan is the difference between cataract-only clinics and those performing vitrectomy.

This is not just a matter of adding equipment.

Vitrectomy requires:

• Additional imaging systems
• Longer operation time
• Skilled staff and workflow adjustments
• Gas management and postoperative considerations

👉 In other words, it is a different operational model

Why “all-in-one” sounds attractive — but can be risky

Unity VCS is positioned as an integrated system.

From a technical standpoint, this is a major advantage.

But in practice, Japanese clinicians often question:

• Will both functions be used enough?
• Will integration improve efficiency — or reduce it?
• Is the increased cost justified by actual usage?

👉 Without clear answers, integration can become overinvestment

The common pitfall: “just in case” decisions

A typical scenario in Japan:

• A clinic is strong in cataract surgery
• Considering future expansion into vitrectomy
• Decides to introduce equipment “just in case”

This often leads to:

• Underutilized equipment
• Increased fixed costs
• No actual expansion into vitrectomy

👉 The issue is not the device — it’s the decision structure

Before choosing the device, define the model

In Japanese practice, the order is clear:

1. Define case volume and surgical model
2. Confirm surgeon availability and workflow
3. Then evaluate the device

Not the other way around.

▶ How Japanese clinics actually evaluate adoption

Rather than asking “Is this device good?”,
the key questions are:

• Will this generate sustainable revenue?
• Can we maintain a stable surgical system?
• Does this improve our core cataract practice?

👉 If these are unclear, adoption is usually postponed

硝子体手術の導入で起こりやすい失敗パターンや、
判断基準を実例ベースで整理しています。

▶ noteはこちら

Conclusion

Unity VCS represents a significant technological step forward.

But in Japan, adoption is rarely driven by technology alone.

👉 The real question is not:

• “Is this a great device?”

But:

• “Does this fit our operational and financial model?”

Understanding this difference is essential to interpreting how new surgical platforms are actually adopted in Japan.